Dermatology: Isotretinoin

Summary

Patients on Isotretinoin treatment (often called known by brand-name Roaccutane and often prescribed for acne) had to present negative pregnancy tests in face-to-face clinics. Female patients to submit pregnancy test results directly onto Isla which the Trust pharmacists can access, allowing the pharmacy to administer the drug without delay.

Patients may also submit their outcome measure forms (DLQI, CADI, PHQ) the day before their appointment sent via an SMS with an encrypted link and outcome measures are then stored digitally and can be aggregated for a specified cohort.

Benefits & savings

5 minutes saved per patient per follow-up appointment

Clinical processes streamlined and reduced administrative burden and waiting times.

Easily viewable sequential records of patients’ visual data and clinical testing results, allowing clinical progress to be monitored over time.

What our users think

“Isla has revolutionised the pathway as we have been able to run a remote clinic which is more effective and much safer. The passive monitoring allows for collaborative treatment in a team, as you have access to sequential photography and all of the data points act as a fail-proof safety net.”

Dermatology: Isotretinoin

Summary

Benefits & savings

What our users think

Quick Links

Useful Links